As the 7-year median follow-up data confirm the previously reported 5-year findings , the conclusion seems warranted that antibody treatment improves the chances of curatively operated patients .
In conclusion , the presented results still support the original hypothesis that minimal residual disease occurring so frequently in patients with sohd tumors appears to be an indication for antibody therapy .
